| Not Yet Recruiting | A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metasta Advanced Esophageal Squamous Cell Carcinoma | Phase 3 | 2026-04-30 |
| Recruiting | A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma | Phase 1 / Phase 2 | 2026-03-31 |
| Not Yet Recruiting | YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer Locally Advanced or Metastatic Breast Cancer | Phase 3 | 2026-03-10 |
| Not Yet Recruiting | Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitiv Non-Small Cell Lung Cancer | Phase 3 | 2026-03-06 |
| Recruiting | A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma. Recurrent or Metastatic Nasopharyngeal Carcinoma | Phase 1 / Phase 2 | 2025-11-05 |
| Recruiting | A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors Advanced Solid Tumors, Non Small Cell Lung Cancer, Small Cell Lung Cancer | Phase 1 / Phase 2 | 2025-10-29 |
| Recruiting | A Study of YL242 in Subjects With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2025-09-22 |
| Recruiting | A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors Advanced Solid Tumors, Breast Cancer, Non Small Cell Lung Cancer | Phase 1 / Phase 2 | 2025-09-02 |
| Recruiting | A Study of YL202 in Patients With Advanced Solid Tumors Non Small Cell Lung Cancer, Colorectal Cancer, Cervical Cancer | Phase 2 | 2025-08-04 |
| Recruiting | A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2025-07-02 |
| Recruiting | A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 3 | 2024-12-31 |
| Recruiting | A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer Small Cell Lung Cancer | Phase 3 | 2024-12-17 |
| Recruiting | A Clinical Study of YL205 in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2024-06-04 |
| Recruiting | A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors | Phase 1 | 2024-05-01 |
| Recruiting | A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BC Locally Advanced or Metastatic Breast Cancer | Phase 2 | 2024-04-23 |
| Recruiting | A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2024-04-17 |
| Recruiting | A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC Metastatic Castration-resistant Prostate Cancer (mCRPC) | Phase 2 | 2024-02-22 |
| Recruiting | A Study of YL202 in Selected Patients With Advanced Solid Tumors NSCLC, Breast Cancer, HNSCC | Phase 2 | 2023-12-15 |
| Active Not Recruiting | A Study YL201 in Patients With Selected Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2023-09-22 |
| Active Not Recruiting | A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer Non Small Cell Lung Cancer, Breast Cancer | Phase 1 | 2022-12-20 |
| Recruiting | A Study of YL201 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2022-05-25 |